Form D · Biotechnology

KIP Biotech, LLC

Minnetonka, MN · CIK 0001477905

Offering snapshot reported Aug 31, 2010 · SEC filing

Reported sold
$1M
Offering amount: $1M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 27, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$500K$1MDec 4, 2009: $250,000.00Dec 4, 2009Aug 31, 2010: $1,000,000.00Aug 31, 2010

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$250,000 → $1,000,000
  • Reported investors5 → 7

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 31, 2010Amendment$1,000,000$750,000vs Dec 4, 20097SEC filing
Dec 11, 2009Initial$250,000No comparison1SEC filing
Dec 4, 2009Initial$250,000No comparison5SEC filing

Offering details

Securities
Debt, Option to acquire, Other
Exemptions
06
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-136601
Convertible Notes

Source: Form D, filed Aug 31, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Furst Director
Gregory Mc Parland Executive
Douglas Metz Director
Bradley Rotter Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
C/O Asa 601 Carlson Parkway
Minnetonka, MN, 55305